Parabilis Medicines, Inc. Common Stock (PBLS) — Tangible Net Worth Ratio
Parabilis Medicines, Inc. Common Stock (PBLS) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($1.05 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Parabilis Medicines, Inc. Common Stock annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Parabilis Medicines, Inc. Common Stock Tangible Net Worth Ratio (2024–2024)
This chart shows how Parabilis Medicines, Inc. Common Stock's Tangible Net Worth Ratio has changed across 1 annual periods from 2024 to 2024. As of June 2026, the ratio stands at 100.0%, reflecting net assets of $1.05 Billion with intangible assets of $0.00 USD.
Annual Tangible Net Worth Ratio for Parabilis Medicines, Inc. Common Stock (2024–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Parabilis Medicines, Inc. Common Stock from 2024 to 2024, covering 1 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see PBLS market cap.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $56.44 Million | $0.00 | $149.25 Million | — |